Ampio Pharmaceuticals
AMPE
#10731
Rank
HK$1.35 M
Marketcap
HK$1.20
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Ampio Pharmaceuticals (AMPE)

EPS in 2023 (TTM): -HK$133.71

According to Ampio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$133.56. In 2022 the company made an earnings per share (EPS) of -HK$169.92 an increase over its 2021 EPS that were of -HK$211.62.

EPS history for Ampio Pharmaceuticals from 2006 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$133.71-21.31%
2022-HK$169.92-19.7%
2021-HK$211.62-0%
2020-HK$211.62-10%
2019-HK$235.14-121.74%
2018HK$1,082-158.23%
2017-HK$1,858119.44%
2016-HK$846.49-41.94%
2015-HK$1,458-18.42%
2014-HK$1,78720.63%
2013-HK$1,48185.29%
2012-HK$799.46-52.11%
2011-HK$1,66944.9%
2010-HK$1,152390%
2009-HK$235.14233.33%
2008-HK$70.54-0%
2007-HK$70.54
2006N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.30-165.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$10.66-107.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$29.39-122.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$337.97-353.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
HK$49.61-137.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-HK$5.88-95.60%๐Ÿ‡บ๐Ÿ‡ธ USA